-+ 0.00%
-+ 0.00%
-+ 0.00%

Altimmune Q1 EPS $(0.18) Beats $(0.25) Estimate.

Benzinga·05/13/2026 11:30:57
Listen to the news
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.25) by 28 percent. This is a 30.77 percent increase over losses of $(0.26) per share from the same period last year.